1. Meroterpenoids with Antiproliferative Activity from a Hawaiian-Plant Associated Fungus Peyronellaea coffeae-arabicae FT238.

    Organic Letters 18(10):2335 (2016) PMID 27135759

    Three unusual polyketide-sesquiterpene metabolites peyronellins A-C (1-3), along with the new epoxyphomalin analog 11-dehydroxy epoxyphomalin A (4), have been isolated from the endophytic fungus Peyronellaea coffeae-arabicae FT238, which was isolated from the native Hawaiian plant Pritchardia lo...
  2. Distinct Metabolic Signature of Human Bladder Cancer Cells Carrying an Impaired Fanconi Anemia Tumor-Suppressor Signaling Pathway.

    Journal of Proteome Research 15(4):1333 (2016) PMID 26956768 PMCID PMC4874490

    Metabolic profiling has great potential to help the diagnosis and prognosis of cancer patients. Fanconi Anemia (FA) tumor-suppressor signaling has been instrumental in understanding human tumorigenesis. However, this instrumental understanding has never been demonstrated at the metabolic level. ...
  3. LINC00472 expression is regulated by promoter methylation and associated with disease-free survival in patients with grade 2 breast cancer.

    Breast Cancer Research and Treatment 154(3):473 (2015) PMID 26564482 PMCID PMC4854534

    Long non-coding RNAs (lncRNAs) are a class of newly recognized DNA transcripts that have diverse biological activities. Dysregulation of lncRNAs may be involved in many pathogenic processes including cancer. Recently, we found an intergenic lncRNA, LINC00472, whose expression was correlated with...
  4. Mutated Fanconi anemia pathway in non-Fanconi anemia cancers.

    Oncotarget 6(24):20396 (2015) PMID 26015400 PMCID PMC4653013

    An extremely high cancer incidence and the hypersensitivity to DNA crosslinking agents associated with Fanconi Anemia (FA) have marked it to be a unique genetic model system to study human cancer etiology and treatment, which has emerged an intense area of investigation in cancer research. Howev...
  5. Targeting the hypoxia pathway to treat pancreatic cancer.

    Drug Design, Development and Therapy 9:2029 (2015) PMID 25897209 PMCID PMC4396576

    The correlation between hypoxia and pancreatic cancer has long been discussed. Hao's research team made many efforts on revealing the oncogenic function of hypoxic inducible factor-1 (HIF-1) in pancreatic cancer progression and development in recent years. Based on their research, they linked mi...
  6. Basal level of FANCD2 monoubiquitination is required for the maintenance of a sufficient number of licensed-replication origins to fire at a normal rate.

    Oncotarget 5(5):1326 (2014) PMID 24658369 PMCID PMC4012723

    Normal DNA replication starts following the stepwise recruitment of replication initiators to assemble Mini-chromosome Maintenance (MCM) 2-7 protein complexes at an adequate amount of DNA replication origins. Under normal conditions, the monoubiquitination of Fanconi Anemia (FA) group D2 protein...
  7. Advances in the understanding of the Fanconi anemia tumor suppressor pathway.

    Cancer Biology & Therapy 14(12):1089 (2013) PMID 24025411 PMCID PMC3912030

    Extremely high cancer incidence in Fanconi anemia (FA) patients has long suggested that the FA signaling pathway is a tumor suppressor pathway. Indeed, our recent findings, for the first time, indicate that the FA pathway plays a significant role in suppressing the development of non-FA human ca...
  8. In vitro FANCD2 monoubiquitination by HHR6 and hRad18.

    Cell Cycle 12(21):3448 (2013) PMID 24036990 PMCID PMC3895433

  9. A hidden role of the inactivated FANCD2: upregulating ΔNp63.

    Oncotarget 4(9):1416 (2013) PMID 23965832 PMCID PMC3824532

    A compromised Fanconi Anemia (FA) signaling pathway, often resulting from an inactivated FANCD2, was recently recognized to contribute to the development of non-FA human tumors. However, it is largely unknown as to how an impaired FA pathway or an inactivated FANCD2 promotes tumorigenesis. Here ...
  10. Recruitment of DNA polymerase eta by FANCD2 in the early response to DNA damage.

    Cell Cycle 12(5):803 (2013) PMID 23388460 PMCID PMC3610727

    How Fanconi anemia (FA) protein D2 (FANCD2) performs DNA damage repair remains largely elusive. We report here that translesion synthesis DNA polymerase (pol) eta is a novel mediator of FANCD2 function. We found that wild type (wt) FANCD2, not K561R (mt) FANCD2, can interact with pol eta. Upon D...
  11. FAVL impairment of the Fanconi anemia pathway promotes the development of human bladder cancer.

    Cell Cycle 11(15):2947 (2012) PMID 22828653 PMCID PMC3419064

    Effectiveness of DNA cross-linking drugs in the treatment of bladder cancer suggests that bladder cancer cells may have harbored an insufficient cellular response to DNA cross-link damage, which will sensitize cells to DNA cross-linking agents. Cell sensitivity benefits from deficient DNA damage...
  12. Wip1 contributes to cell homeostasis maintained by the steady-state level of Wtp53.

    Cell Cycle 10(15):2574 (2011) PMID 21734451 PMCID PMC3180196

    Wip1, a human protein Ser/Thr phosphatase also called PPM1D, stands for wild type p53 induced phosphatase 1. Emerging evidences indicate that Wip1 can act as an oncogene largely by turning off DNA damage checkpoint responses. Here we report an unrecognized role of Wipl in normally growing cells....
  13. Convergence of Rad6/Rad18 and Fanconi anemia tumor suppressor pathways upon DNA damage.

    PLoS ONE 5(10):e13313 (2010) PMID 20967207 PMCID PMC2954165

    Extremely high cancer incidence associated with patients with Fanconi anemia (FA) suggests the importance of the FA signaling pathway in the suppression of non-FA human tumor development. Indeed, we found that an impaired FA signaling pathway substantially contributes to the development of non-F...
  14. RNA helicase and colon cancer.

    Cancer Biology & Therapy 7(10):1677 (2008) PMID 18787419

  15. FANCD2 monoubiquitination provides a link between the HHR6 and FA-BRCA pathways.

    Cell Cycle 7(3):407 (2008) PMID 18277096

    Fanconi Anemia (FA) is a rare genetic disease characterized by chromosome instability mostly resulting from an improper regulation of FANCD2 monoubiquitination. The E2 ubiquitin conjugating enzyme UBE2T along with a multi-protein E3 ubiquitin-ligase complex containing a catalytic subunit FANCL m...
  16. Altered expression of FANCL confers mitomycin C sensitivity in Calu-6 lung cancer cells.

    Cancer Biology & Therapy 5(12):1632 (2006) PMID 17106252

    Fanconi anemia (FA) results from mutations in a group of genes whose products, including BRCA2 and BACH1/BRIP1, are known to function in one common pathway (the FA-BRCA pathway) to guard genome integrity, especially when challenged by DNA crosslinking agents, such as Cisplatin and mitomycin C (M...
  17. DR5 knockout mice are compromised in radiation-induced apoptosis.

    Molecular and Cellular Biology 25(5):2000 (2005) PMID 15713653 PMCID PMC549384

    DR5 (also called TRAIL receptor 2 and KILLER) is an apoptosis-inducing membrane receptor for tumor necrosis factor-related apoptosis-inducing ligand (also called TRAIL and Apo2 ligand). DR5 is a transcriptional target of p53, and its overexpression induces cell death in vitro. However, the in vi...
  18. New advances in the DNA damage response network of Fanconi anemia and BRCA proteins. FAAP95 replaces BRCA2 as the true FANCB protein.

    Cell Cycle 4(1):80 (2005) PMID 15611632

    Fanconi anemia (FA) proteins function in a DNA damage response pathway that appears to be part of the network including breast cancer susceptibility gene products, BRCA1 and BRCA2. In response to DNA damage or replication signals, a nuclear FA core complex of at least 6 FA proteins (FANCA, FANCC...
  19. Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth.

    Cancer Cell 6(6):597 (2004) PMID 15607964

    p53-dependent apoptosis is a major determinant of its tumor suppressor activity and can be triggered by hypoxia. No p53 target is known to be induced by p53 or to mediate p53-dependent apoptosis during hypoxia. We report that p53 can directly upregulate expression of Bnip3L, a cell death inducer...
  20. P53 and radiation responses.

    Oncogene 22(37):5774 (2003) PMID 12947385

    Cells have evolved elaborate mechanisms (checkpoints) to monitor genomic integrity in order to ensure the high-fidelity transmission of genetic information. Cells harboring defects in checkpoint pathways respond to DNA damage improperly, which in turn may enhance the rate of cancer development. ...